---
title: "Eyebright Medical: The Focus Deep Extended Artificial Lens has been approved for market launch through the Innovative Medical Device Special Review Procedure"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259013074.md"
description: "Eyebright Medical announced that its \"Extended Depth of Focus Intraocular Lens\" has been approved for market launch through the special review procedure for innovative medical devices by the National Medical Products Administration. This product is a high-end refractive intraocular lens suitable for vision correction in adults with aphakia after cataract removal surgery, aimed at improving intermediate vision and reducing dependence on glasses"
datetime: "2025-09-26T08:34:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259013074.md)
  - [en](https://longbridge.com/en/news/259013074.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259013074.md)
---

# Eyebright Medical: The Focus Deep Extended Artificial Lens has been approved for market launch through the Innovative Medical Device Special Review Procedure

According to the Zhitong Finance APP, Eyebright Medical (688050.SH) announced that its "Extended Depth of Focus Intraocular Lens" has recently been approved for registration by the National Medical Products Administration through the special review for innovative medical devices.

The Extended Depth of Focus Intraocular Lens is a high-end refractive intraocular lens suitable for vision correction in adults after cataract removal surgery in eyes without a lens. It achieves extended depth of focus through a higher-order aspheric design, improving intermediate vision while not significantly reducing distance vision, thereby reducing dependence on glasses

### Related Stocks

- [688050.CN](https://longbridge.com/en/quote/688050.CN.md)

## Related News & Research

- [Polytechnic students create AI chatbot to improve access to special needs resources and support](https://longbridge.com/en/news/286932477.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [Cagent Vascular closes oversubscribed $41 million Series D financing round](https://longbridge.com/en/news/287114819.md)
- [Trump signs order aimed at preventing illicit financial activity, White House says](https://longbridge.com/en/news/286970478.md)